GSK3B and neoplasm: SCs drive epithelial–mesenchymal transition (EMT) and enhance metastatic potential in lung cancer through pathways involving CXCL‐5/CXCR‐2/PI3K/AKT and GSK‐3β/Snail–Twist, demonstrating distinct tumor‐promoting behavior [452].